The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of myopia in children. Considered a common ...

Purpose: The effects of wide temperature variations on the stability of atropine, epinephrine, and lidocaine stored under field conditions in advanced life support (ALS) paramedic units were ...

The pharmacological treatment of bradycardia and atrioventricular conduction disturbances during STEMI is a therapeutic, not prophylactic, measure. Pharmacotherapy centers on the use of atropine ...